Intas Marbomet 50mg Advanced Veterinary Fluoroquinolone Antibacterial Tablets for Small to Medium Dogs & Cats

Select Variant: 1 strip (5 tablets)

Description

Overcome antimicrobial resistance, clear deep-seated skin infections, and resolve stubborn urinary tract infections in cats and smaller canines with Intas Marbomet 50mg Tablets, available online at VetMitra. In small animal clinical medicine across India, superficial and deep bacterial infections in cats and small-breed dogs (such as Pugs, Shih Tzus, French Bulldogs, and Beagles) are increasingly failing first-line beta-lactams and basic cephalosporins. Pathogens such as beta-lactamase-producing Staphylococcus pseudintermedius, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Pasteurella multocida frequently develop enzymatic defenses that neutralize standard penicillins.When standard treatments stall, continuing degraded or bacteriostatic therapies risks chronic tissue scarring, irreversible renal damage, or recurrent fistulas.Intas Marbomet 50mg delivers targeted, bactericidal efficacy via modern fluoroquinolone pharmacology:Dual-Enzyme Bactericidal Cleavage (Marbofloxacin 50mg): Developed specifically for companion animal medicine, marbofloxacin penetrates bacterial envelopes to inhibit two vital bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. Inhibiting these enzymes blocks DNA supercoiling, transcription, and replication, triggering rapid autolytic fragmentation of the bacterial chromosome.Concentration-Dependent Killing ($C_{\max}/\text{MIC}$): Exhibits rapid, concentration-dependent bacterial kill and a sustained post-antibiotic effect (PAE). High peak drug concentrations suppress bacterial replication quickly, reducing the risk of resistant sub-populations emerging.Tissue Bioavailability & Penetration: Displays near-100% oral bioavailability with minimal plasma protein binding. It penetrates deeply into infected tissues, concentrating heavily in cutaneous tissue, bronchial secretions, feline bite abscess cavities, pulmonary macrophages, and urine at levels exceeding serum concentrations.Effective Against Beta-Lactamase Pathogens: Because its mechanism targets intracellular bacterial topoisomerases rather than cell-wall penicillin-binding proteins, marbofloxacin remains fully active against penicillinase-, cephalosporinase-, and ESBL-producing bacteria.Superior Feline Ocular Safety: Unlike older fluoroquinolones like enrofloxacin—which carry a well-documented risk of causing acute, irreversible retinal degeneration and total blindness in cats—marbofloxacin features a significantly wider margin of ocular and retinal safety in feline patients when dosed within therapeutic limits.Scored Tablet for Precision Weight Titration: The 50mg strength allows clean, accurate splitting for cats and small dogs weighing 5 kg to 18 kg, avoiding the risks of fractional guesswork from large 150mg adult tablets.Convenient Once-Daily Dosing (SID): Maintains bactericidal levels above the MIC over 24 hours, simplifying dosing schedules and reducing stress for both pets and owners.